Table 6.
Multivariable Cox proportional hazards model for three year overall survival.
| Overall | HR | p-Value | [95%CI] |
| mEHT | 0.72 | 0.074 | 0.51–1.03 |
| HIV-negative | 0.84 | 0.366 | 0.58–1.23 |
| Age at Enrolment | 0.98 | 0.019 | 0.96–1.00 |
| FIGO Stage | 1.10 | 0.619 | 0.76–1.59 |
| FIGO Stage II | HR | p-Value | [95%CI] |
| mEHT | 0.91 | 0.748 | 0.51–1.64 |
| HIV-negative | 0.75 | 0.365 | 0.40–1.40 |
| Age at Enrolment | 0.99 | 0.468 | 0.96–1.02 |
| FIGO Stage III | HR | p-Value | [95%CI] |
| mEHT | 0.62 | 0.040 | 0.40–0.98 |
| HIV-negative | 0.93 | 0.777 | 0.58–1.50 |
| Age at Enrolment | 0.97 | 0.018 | 0.95–0.99 |
Abbreviations: FIGO: Fédération Internationale de Gynécologie et d’Obstétrique; HIV: Human Immunodeficiency Virus; HR: Hazard Ratio; mEHT: Modulated Electro-Hyperthermia.